Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy

Article Abstract:

HIV patients whose CD4 T cell counts increase to 200 or more in response to antiretroviral therapy can stop taking drugs to prevent Pneumocystis carinii pneumonia (PCP). In a study of 325 such patients, none developed PCP during an average of 13 months after they stopped taking drugs to prevent PCP.

Author: Reiss, Peter, Ledergerber, Bruno, Mocroft, Amanda, Furrer, Hansjakob, Kirk, Ole, Bickel, Markus, Uberti-Foppa, Caterina, Pradier, Christian, Monforte, Antonella D'Arminio, Schneider, Margriet M.E., Lundgren, Jens D.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2001
Pneumocystis carinii pneumonia

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Regional differences in use of antiretroviral agents and primary prophylaxis in 3,122 European HIV-infected patients

Article Abstract:

This study points out that once clinical trials are finished, actual use of drugs designed to protect HIV-infected patients from opportunistic infections may vary widely. It was learned that this is the case across Europe, and guidelines have not been followed.

Author: Vella, Stefano, Clumeck, Nathan, Phillips, Andrew N., Gatell, Jose, Reiss, Peter, Ledergerber, Bruno, Lundgren, Jens D., Dietrich, Manfred, Johnson, Anne M., Pedersen, Court, Katlama, Christine, Benfield, Thomas L., Nielsen, Jens O.
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
Subject: Health
ISSN: 1077-9450
Year: 1997
Usage, HIV patients, Opportunistic infections

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

HIV Viral Load Response to Antiretroviral Therapy According to the Baseline CD4 Cell Count and Viral Load. (Original Contribution)

Article Abstract:

HIV patients whose CD4 T cell counts are less than 200 may still respond to highly active antiretroviral therapy (HAART), according to a study 3,226 patients. This was true even in patients who had large amounts of virus in their blood.

Author: Weber, Rainer, Vernazza, Pietro, Phillips, Andrew N., Ledergerber, Bruno, Kirk, Ole, Lundgren, Jens D., Staszewski, Schlomo, Miller, Veronica, Francioli, Patrick
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2001
Viremia

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Prevention, HIV infection, Drug therapy, HIV infections
Similar abstracts:
  • Abstracts: Aerosol pentamidine for secondary prophylaxis of AIDS-related Pneumocystis carinii pneumonia: a randomized, placebo-controlled study
  • Abstracts: Aerosol pentamidine for secondary prophylaxis of AIDS-related Pneumocystis carinii pneumonia: a randomized, placebo-controlled study. part 2
  • Abstracts: Pivotal role of early and sustained infarct vessel patency in patients with acute myocardial infarction. Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis
  • Abstracts: Localization of endocrine tumors of the pancreas with endoscopic ultrasonography. Preoperative staging of esophageal cancer: comparison of endoscopic US and dynamic CT
  • Abstracts: Interleukin-6 in relation to other proinflammatory cytokines, chemotactic activity and neutrophil activation ion rheumatoid synovial fluid
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.